Navigation Links
Sunflowers Could Hold the Key to New Class of AIDS Drugs

Scientists at the University of Bonn in Germany have come up with what could be a potential AIDS drug. They have found that a substance present in sunflowers prevents // the AIDS virus from replicating in cell cultures. It is not yet known if this would also apply to the actual disease.

The substance called as 'DCQA' has been the sole hope of producing a new class of AIDS drugs. But this is available in very minute quantities and naturally is pretty costly. The researchers from Bonn worked in collaboration with the Caesar research centre to make this substance available at a fraction of the earlier costs. The attempt to find the substance in sunflowers started with a mould called sclerotinia sclerotiorum. It was found that some varieties of sunflower were resistant to a disease called "white stem rot' that destroys the crops. Agricultural engineer Claudio Cerboncini proceeded to isolate the substance that confers protection on the sunflowers that are resistant to this fungal disease. The substance was dicaffeoyl quinic acid, or DCQA. "Dicaffeoyl quinic acid can prevent the HI virus from reproducing, at least in cell cultures," said Claudio Cerboncini.

"It is one of the few substances known today which inhibit viral integrase - this is an enzyme which is essential if the pathogen is to reproduce." Preliminary clinical tests have now borne out the hope that DCQA could herald in a new class of AIDS drugs. Dr. Esther Vogt of the Immunological Out-Patient Service of Bonn University Clinic, said, "We need these substances to expand our arsenal of effective weapons against the disease. It remains to be seen, however, whether they will prove to be as effective in clinical practice as they seem to be at present." The University of Bonn researchers have teamed up with Jülich Research Centre to see if they can manufacture this substance on a large scale.

Contact
Dr. Ralf Theisen
r.theisen@uni-bonn.de
University of Bonn
www.un i-bonn.de

'"/>




Related medicine news :

1. Oleic-acid-rich Sunflowers Give Trans-fat Alternative - Study
2. Lean Protein Could Be Key to Obesity Drugs
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Nasal Spray Could Take Drugs Directly to Brain
5. Oxygen Usage During Exercise Could Indicate Heart Problems
6. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
7. Anger Could Be Linked To Weight Gain
8. A Seizure Late In Life Could be A Stroke Warning
9. New Findings Could Reduce The Extent Of Spinal Cord Injuries
10. Could There Be A Link Between Famine and Breast Cancer ?
11. Bone Marrow Cells Could Yield A New Lease of Life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... Fla. (PRWEB) , ... March 27, 2017 , ... The ... and the number of homeowners utilizing DIY and unlicensed contractors for renovations is also ... remodel or replacement project in 2015, and of those, 42% failed to use a ...
(Date:3/26/2017)... ... March 26, 2017 , ... ... receive the RealSelf 100 Award, a prestigious award honoring the top influencers on ... to find and connect with doctors and clinics. , In 2016, more than ...
(Date:3/25/2017)... ... ... Norland at Swissray is pleased to announce the release of the ELITE DXA, a ... an active scan window, which is more than double that of existing bone densitometers. ... not undergo an accurate total body bone density or body composition study. The ...
(Date:3/24/2017)... ... March 24, 2017 , ... Vighter ... the same time by providing Prehospital Trauma Life Support (PHTLS) course scholarships to ... premier prehospital trauma education developed in cooperation with the American College of Surgeons ...
(Date:3/24/2017)... York, NY (PRWEB) , ... March 24, 2017 ... ... global scale; from third world countries to hospitals in the United States, it’s ... a conversation on the current obstacles facing infection prevention and offers strategies for ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , Mar. 24, 2017 Research and Markets has ... Analysis, 2016" report to their offering. ... The IPF pipeline is very strong with a total ... & Co., Inc., Biogen and Sanofi are involved in the development of ... which one is in Phase III stage, 15 are in Phase II ...
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... Global Strategic Business Report" report to their offering. ... The report provides separate comprehensive analytics for ... Europe , Asia-Pacific , ... are provided for the period 2015 through 2022. Also, a six-year historic ...
(Date:3/24/2017)... 2017  Provectus Biopharmaceuticals, Inc. (OTCQB: PVCT, ... oncology and dermatology biopharmaceutical company, today disclosed terms ... Sheet (the "Definitive Financing") it entered into on ... stockholders, who are referred to in the Definitive ... filed with the Securities and Exchange Commission.   ...
Breaking Medicine Technology: